From Monitoring the Commitment to Inoculations among Healthcare Workers during the COVID-19 Pandemic to Overcoming Communication Risks in the Process of Vaccination
T. A. Platonova,
A. A. Golubkova,
M. S. Sklyar,
Е I. Sisin,
S. S. Smirnova,
T. R. Tomenko,
M. S. Rozhkov https://doi.org/10.35627/2219-5238/2023-31-1-13-19
Abstract
Introduction: The epidemic process of the novel coronavirus disease (COVID-19) can be managed only through vaccination. Yet, despite the availability of effective immunobiological preparations, health administrators often face a negative attitude of the population, including healthcare professionals, to vaccination.
Objective: To establish commitment of workers of health facilities to vaccination against COVID–19 during different periods of the pandemic using modern online resources and to justify the need to develop effective practices of dealing with communicative risks in the course of vaccination.
Materials and methods: The study was conducted in several successive stages corresponding to five waves of the COVID-19 pandemic in the Russian Federation by means of an online survey of 5,304 health workers using Google Forms. We applied sociological and statistical methods of research.
Results: We observed that the attitude to vaccination against COVID-19 among the employees of health institutions was ambiguous and changed over time demonstrating a gradual increase in adherence to inoculations. The potential risk group with a negative attitude towards vaccination included female nurses and workers of non-medical specialties with less than five years of work experience. An insufficient level of commitment to coronavirus vaccination among the personnel of health facilities has been also noted in other countries, which is a serious problem on a global scale hindering the victory over this novel infection.
Conclusion: We assessed commitment to inoculations against COVID-19 among medical workers using modern online resources and found its inadequate level necessitating effective interventions aimed at awareness raising and training in modern practices of effective communications.
About the Authors
T. A. Platonova
European Medical Center “UMMC–Health”
Tatyana A. Platonova, Cand. Sci. (Med), Head of the Department of Epidemiology, epidemiologist, European Medical Center “UMMC–Health”;
Scheinkman Street, Yekaterinburg, 620144
A. A. Golubkova
Central Research Institute of Epidemiology; Russian Medical Academy of Continuous Professional Education
Russian Federation
Russian Federation
Alla A. Golubkova, Dr. Sci. (Med.), Prof., Leading Researcher, Laboratory of Healthcare-Associated Infections, Central Research Institute of Epidemiology; Professor, Department of Epidemiology, Russian Medical Academy of Continuous Professional Education
3А Novogireevskaya Street, Moscow, 111123
Bldg 1, 2/1 Barrikadnaya Street, Moscow, 125993
M. S. Sklyar
European Medical Center “UMMC–Health”; Ural Mining and Metallurgical Company (UMMC)
Russian Federation
Russian Federation
Mikhail S. Sklyar, Dr. Sci. (Med.), Director General, European Medical Center “UMMC–Health”, Advisor to the UMMC Director General
113 Scheinkman Street, Yekaterinburg, 620144
1 Uspensky Avenue, Verkhnyaya Pyshma, 624091
Е I. Sisin
Khanty-Mansiysk State Medical Academy; Center for Hygiene and Epidemiology in the Khanty-Mansi Autonomous Okrug – Yugra
Russian Federation
Russian Federation
Еvgeniy I. Sisin, Cand. Sci. (Med.), Assoc. Prof., Department of Infectious Diseases with the Course of Epidemiology, Khanty-Mansiysk State Medical Academy; epidemiologist, Department of Epidemiological Surveillance, Center for Hygiene and Epidemiology in the Khanty-Mansi Autonomous Okrug
40 Mira Street, Khanty-Mansiysk, 628011
72 Roznin Street, Khanty-Mansiysk, 628011
S. S. Smirnova
Yekaterinburg Research Institute of Viral Infections, State Research Center for Virology and Biotechnology “Vector”; Ural State Medical University
Russian Federation
Russian Federation
Svetlana S. Smirnova, Cand. Sci. (Med.), Head, Ural-Siberian Scientific and Methodological Center for Prevention of Healthcare-Associated Infections, Yekaterinburg Research Institute of Viral Infections, State Research Center for Virology and Biotechnology “Vector”; Assoc. Prof., Department of Epidemiology, Social Hygiene and Organization of State Sanitary and Epidemiological Service, Ural State Medical University
23 Letnyaya Street, Yekaterinburg, 620030
3 Repin Street, Yekaterinburg, 620028
T. R. Tomenko
European Medical Center “UMMC–Health”; Ural State Medical University; Ural Federal University named after the First President of Russia B.N. Yeltsin
Russian Federation
Russian Federation
Tatiana R. Tomenko, Cand. Sci. (Med.), Head, Center for Brain Dysfunction and Epilepsy, European Medical Center “UMMC–Health”; Assistant, Department of Neurology, Neurosurgery and Medical Genetics, Ural State Medical University; Head, Human Cognition and Behavior Research Laboratory, Ural Federal University named after the First President of Russia B.N. Yeltsin
113 Scheinkman Street, Yekaterinburg, 620144
3 Repin Street, Yekaterinburg, 620028
19 Mira Street, Yekaterinburg, 620002
M. S. Rozhkov
Ural Federal University named after the First President of Russia B.N. Yeltsin
Russian Federation
Russian Federation
Mikhail S. Rozhkov, Researcher, Human Cognition and Behavior Research Laboratory, Ural Federal University named after the First President of Russia B.N. Yeltsin
19 Mira Street, Yekaterinburg, 620002
References
1. Briko NI, Kagramanyan IN, Nikiforov VV, Suranova TG, Chernyavskaya OР, Polezhaeva NA. Pandemic COVID-19. Prevention measures in the Russian Federation. Epidemiologiya i Vaktsinoprofilaktika. 2020;19(2):4-12. (In Russ.) doi: 10.31631/2073-3046-2020-19-2-4-12
2. Mohamadian M, Chiti H, Shoghli A, Biglari S, Parsamanesh N, Esmaeilzadeh A. COVID-19: Virology, biology and novel laboratory diagnosis. J Gene Med. 2021;23(2):e3303. doi: 10.1002/jgm.3303
3. Alsharif W, Qurashi A. Effectiveness of COVID-19 diagnosis and management tools: A review. Radiography (Lond). 2021;27(2):682687. doi: 10.1016/j.radi.2020.09.010
4. Samudrala PK, Kumar P, Choudhary K, et al. Virology, pathogenesis, diagnosis and in-line treatment of COVID-19. Eur J Pharmacol. 2020;883:173375. doi: 10.1016/j.ejphar.2020.173375
5. Muralidar S, Ambi SV, Sekaran S, Krishnan UM. The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie. 2020;179:85-100. doi: 10.1016/j.biochi.2020.09.018.
6. Hossain MM, Tasnim S, Sultana A, et al. Epidemiology of mental health problems in COVID-19: a review. F1000Res. 2020;9:636. doi: 10.12688/f1000research.24457.1.
7. Onyeaka H, Anumudu CK, Al-Sharify ZT, Egele-Godswill E, Mbaegbu P. COVID-19 pandemic: A review of the global lockdown and its far-reaching effects. Sci Prog. 2021;104(2):368504211019854. doi: 10.1177/00368504211019854.
8. Menges D, Ballouz T, Anagnostopoulos A, et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PLoS One. 2021;16(7):e0254523. doi: 10.1371/journal.pone.0254523.
9. Mamun MA, Sakib N, Gozal D, et al. The COVID-19 pandemic and serious psychological consequences in Bangladesh: A population-based nationwide study. J Affect Disord. 2021;279:462-472. doi: 10.1016/j.jad.2020.10.036.
10. Papadopoulou A, Efstathiou V, Yotsidi V, et al. Suicidal ideation during COVID-19 lockdown in Greece: Prevalence in the community, risk and protective factors. Psychiatry Res. 2021;297:113713. doi: 10.1016/j.psychres.2021.113713.
11. Chen PJ, Pusica Y, Sohaei D, Prassas I, Diamandis EP. An overview of mental health during the COVID-19 pandemic. Diagnosis (Berl). 2021;8(4):403-412. doi: 10.1515/dx-2021-0046.
12. Capra ME, Stanyevic B, Giudice A, et al. The Effects of COVID-19 Pandemic and Lockdown on Pediatric Nutritional and Metabolic Diseases: A Narrative Review. Nutrients. 2022;15(1):88. doi: 10.3390/nu15010088.
13. Kharchenko EP. Vaccines against Covid-19: The comparative estimates of risks in adenovirus vectors. Epidemiologiya i Vaktsinoprofilaktika. 2020;19(5):4-17. (In Russ.) doi: 10.31631/20733046-2020-19-5-4-17
14. Kharchenko EP. Vaccines against Covid-19: Comparison, limitations, the decrease of pandemic and the perspective of viral respiratory. Epidemiologiya i Vaktsinoprofilaktika 2021;20(1):4-19. (In Russ.) doi: 10.31631/2073-3046-2021-20-1-4-19
15. Logunov DY, Dolzhikova IV, Zubkova OV, et al. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia. Lancet. 2020;396(10255):887-897. doi: 10.1016/S0140-6736(20)31866-3
16. Logunov DY, Dolzhikova IV, Shcheblyakov DV, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: An interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8
17. Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Eur Rev Med Pharmacol Sci. 2021;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
18. Mehrotra DV, Janes HE, Fleming TR, et al. Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials. Ann Intern Med. 2021;174(2):221-228. doi: 10.7326/M20-6169.
19. Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021;21(10):626-636. doi: 10.1038/s41577-021-00592-1.
20. Hodgson SH, Mansatta K, Mallett G, Harris V, Emary KRW, Pollard AJ. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis. 2021;21(2):e26-e35. doi: 10.1016/ S1473-3099(20)30773-8.
21. Soleimanpour S, Yaghoubi A. COVID-19 vaccine: where are we now and where should we go? Expert Rev Vaccines. 2021;20(1):23-44. doi: 10.1080/14760584.2021.1875824.
22. Fang E, Liu X, Li M, et al. Advances in COVID-19 mRNA vaccine development. Signal Transduct Target Ther. 2022;7(1):94. doi: 10.1038/s41392-022-00950-y.
23. Chalkias S, Harper C, Vrbicky K, et al. A Bivalent Omicron-Containing Booster Vaccine against Covid-19. N Engl J Med. 2022;387(14):12791291. doi: 10.1056/NEJMoa2208343.
24. Feikin DR, Higdon MM, Abu-Raddad LJ, et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022;399(10328):924-944. doi: 10.1016/S0140-6736(22)00152-0.
25. Francis AI, Ghany S, Gilkes T, Umakanthan S. Review of COVID-19 vaccine subtypes, efficacy and geographical distributions. Postgrad Med J. 2022;98(1159):389-394. doi: 10.1136/postgradmedj-2021-140654.
26. Creech CB, Anderson E, Berthaud V, et al. Evaluation of mRNA1273 Covid-19 Vaccine in Children 6 to 11 Years of Age. N Engl J Med. 2022;386(21):2011-2023. doi: 10.1056/NEJMoa2203315.
27. Graña C, Ghosn L, Evrenoglou T, et al. Efficacy and safety of COVID-19 vaccines. Cochrane Database Syst Rev. 2022;12(12):CD015477. doi: 10.1002/14651858.CD015477.
28. Dai L, Gao L, Tao L, et al. Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults. N Engl J Med. 2022;386(22):2097-2111. doi: 10.1056/NEJMoa2202261.
29. Prakash S. Development of COVID 19 vaccine: A summarized review on global trials, efficacy, and effectiveness on variants. Diabetes Metab Syndr. 2022;16(4):102482. doi: 10.1016/j.dsx.2022.102482.
30. Ermolenko KD, Kharit SM, Ruleva AA, Drozdova LYu. Establishing a dialogue with a patient on vaccination (scientific review). Epidemiologiya i Vaktsinoprofilaktika. 2021;20(1):114-124. (In Russ.) doi: 10.31631/2073-3046-2021-20-1-114-124
31. Golubkova AA, Platonova TA, Semenenko TA, Smirnova SS, Nikitskaya AD, Chikunova MV. Multi-level monitoring of vaccination adherence of various population groups in the context of the COVID-19 pandemic: Problematic issues. Epidemiologiya i Vaktsinoprofilaktika. 2021;20(6):2836. (In Russ.) doi: 10.31631/2073-3046-2021-20-6-28-36
32. Galina NP. Analysis of the attitude towards immunization of doctors of various specialties. Epidemiologiya i Vaktsinoprofilaktika. 2018;17(3):74-79. (In Russ.) doi: 10.31631/2073-3046-2018-17-3-74-79
33. Hajure M, Tariku M, Bekele F, et al. Attitude towards COVID-19 vaccination among healthcare workers: A systematic review. Infect Drug Resist. 2021;14:3883-3897. doi: 10.2147/IDR.S332792
34. Luo C, Yang Y, Liu Y, et al. Intention to COVID-19 vaccination and associated factors among health care workers: A systematic review and meta-analysis of cross-sectional studies. Am J Infect Control. 2021;49(10):1295-1304. doi: 10.1016/j.ajic.2021.06.020
35. Li M, Luo Y, Watson R, et al. Healthcare workers' (HCWs) attitudes and related factors towards COVID-19 vaccination: A rapid systematic review. Postgrad Med J. 2021;postgradmedj-2021-140195. doi: 10.1136/postgradmedj-2021-140195
Review
For citations:
Platonova T.A., Golubkova A.A., Sklyar M.S., Sisin Е.I., Smirnova S.S., Tomenko T.R., Rozhkov M.S. From Monitoring the Commitment to Inoculations among Healthcare Workers during the COVID-19 Pandemic to Overcoming Communication Risks in the Process of Vaccination. Public Health and Life Environment – PH&LE. 2023;31(1):13-19. (In Russ.) https://doi.org/10.35627/2219-5238/2023-31-1-13-19
Views:
478
.png)
Email this article 